Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

ANTIDOTES AND POTENTIATING AGENTS FOR PHOSPHOLINE IODIDE

Robert A. Lehman, Howard M. Fitch, Lillian P. Bloch, Howard A. Jewell and Maude E. Nicholls
Journal of Pharmacology and Experimental Therapeutics March 1960, 128 (3) 307-317;
Robert A. Lehman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard M. Fitch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lillian P. Bloch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard A. Jewell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maude E. Nicholls
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

On simultaneous intraperitoneal injection in the mouse, the quaternary oximes, Protopam (2-PAM) and TMB4 raised the lethal dose of Phospholine by factors of 24 and 220 respectively. Protopam rapidly reversed the muscarinic and nicotinic effects of Phospholine in the anesthetized cat on heart rate, blood pressure, respiration and isometric twitch tension of indirectly stimulated skeletal muscle. In survival experiments in cats, Protopam was preferred over atropine and Probanthine as an antidote against Phospholine toxicity since it immediately restored spontaneous respiration, but the latter drugs were also effective when given together with artificial respiration.

Protopam reacts with Phospholine in vitro but probably too slowly to account for its antidotat action. Both Protopam and TMB4 reactivate Phospholine-inhibited acetylcholinesterase of whole mouse blood rapidly in the continued presence of inhibitor and resistance of the enzyme to Phospholine is maintained after dilution of the oxime to an ineffective level. It appears that enzyme reactivation must be considered a significant factor in the antidotal action in vivo.

Neostigmine, Mestinon and Humorsol were slightly protected by simultaneous administration of Protopam or TMB4. In each case the latter was more effective than the former. The lethal doses of Mytelase and Tensilon were not significantly modified by the oximes.

Phospholine and Mytelase exhibited mutual potentiation of toxicity by a factor of 53 or 186 depending upon the experimental conditions. Minor potentiation was also seen among some of the other drugs studied.

Footnotes

    • Received August 7, 1959.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 128, Issue 3
1 Mar 1960
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ANTIDOTES AND POTENTIATING AGENTS FOR PHOSPHOLINE IODIDE
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

ANTIDOTES AND POTENTIATING AGENTS FOR PHOSPHOLINE IODIDE

Robert A. Lehman, Howard M. Fitch, Lillian P. Bloch, Howard A. Jewell and Maude E. Nicholls
Journal of Pharmacology and Experimental Therapeutics March 1, 1960, 128 (3) 307-317;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

ANTIDOTES AND POTENTIATING AGENTS FOR PHOSPHOLINE IODIDE

Robert A. Lehman, Howard M. Fitch, Lillian P. Bloch, Howard A. Jewell and Maude E. Nicholls
Journal of Pharmacology and Experimental Therapeutics March 1, 1960, 128 (3) 307-317;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Activation of G Proteins by Neuropeptide Y and γ-Aminobutyric AcidB Receptor Agonists in Rat Cerebral Cortical Membranes through Distinct Modes of Action
  • Adenosine A1 Receptor Antagonist KW-3902 Prevents Hypoxia-Induced Renal Vasoconstriction
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics